Patent · US Active

IL-2Rgamma binding compounds

US11548914B2 · kind B2 · utility

0Cited by
5References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 27, 2020
Grant dateJan 10, 2023
Priority date
Expiry dateMay 27, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

IL-2Rβ ligands and IL-2Rγc ligands and compounds comprising the ligands are disclosed. The ligands and compounds such as heterodimers and fusion proteins comprising the IL-2Rβ ligands and/or the IL-2Rγc ligands can be IL-2 receptor agonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.